Recruiting Myelofibrosis Studies in Palo Alto
About Myelofibrosis Clinical Trials in Palo Alto
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 1 myelofibrosis clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 256 participants. Research is being sponsored by Ajax Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in Palo Alto — FAQ
Are there myelofibrosis clinical trials in Palo Alto?
Yes, there are 1 myelofibrosis clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated October 16, 2026 from ClinicalTrials.gov